NEW YORK (PRWEB) September 18, 2007
In 2007, SBi has expanded its range by launching ten new systems in the thumb, wrist, elbow and foot & ankle, and received FDA clearance to market a further six products.
SBi just rolled out Artelon(R) Arthro and Artelon STT degradable spacers to treat arthritis in the thumb with tissue-sparing and function restoring benefits of the successful Artelon CMC-1 and Artelon LG spacers. An estimated 4,000 spacers have been implanted to date.
In its Wrist Repair portfolio FDA clearance of SBi's distal radius plating system, PRECISE SD(TM), follows the rollout of the STABILITY(TM) Sigmoid Notch Total DRUJ System(TM). It is believed to be the only true anatomic replacement option in the U.S. for the principal wrist joint.
SBi's Elbow Management System now includes the rHead(TM) Elbow Plating System and a minimally invasive rHead(TM) Lateral Radial Head Implant. This system provides a unique locking mechanism between the radial head and stem. SBi's UNI-Elbow(TM) is the first uni-compartmental arthroplasty commercially available in the U.S. and is compatible with all three rHead(TM) prostheses.
Developments in the foot & ankle sector include the RingFIX(TM) 'next generation' external fixation system and six recent FDA clearances for patients with a variety of foot & ankle complaints.
About Mr. Frederick and Small Bone Innovations
Christopher J. Frederick
Senior VP, Sales & Worldwide Marketing, Small Bone Innovations, Inc.
Before joining SBI, in November 2005, Mr. Frederick spent 16 years with Johnson & Johnson in the Medical Device Division at Ethicon Endo-surgery and Cordis Endovascular. He was VP of Marketing for Cordis Endovascular and led the integration of Market Development, US Marketing, Global and Marketing Communications. Prior to Cordis, Mr. Frederick held senior positions at Ethicon Endo-Surgery in Ohio and in the Pacific Northwest.
Mr. Frederick has more than 20 years experience in Medical Device Marketing and Sales & holds a BS in Business Administration and Marketing from Bloomsburg University.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC, (VB), the New York-based venture capital, private equity and merchant banking firm that specializes in the musculoskeletal/orthopedic sector. By integrating established companies and management, SBi has more than 130 employees at facilities in New York, NY, Morrisville, PA and Bourg-en-Bresse, France.
For more information about SBi, please visit: http://www.totalsmallbone.com
This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting SBi's business including increased competition; the ability of SBi to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.